Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

EGFR mutation + YAP1 overexpression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

EGFR exon 19 deletion (79)

EGFR amplification (52)

EGFR exon 18 deletion (3)

EGFR exon 2-7 deletion + EGFR amplification (2)

EGFR amplification + ERBB2 amplification (1)

EGFR exon 19 deletion + HER-2 amplification (1)

EGFR exon 21 deletion (1)

EGFR T790M + exon 19 deletion (0)

EGFR amplifcation (0)

EGFR exon 19 deletion (79)

EGFR amplification (52)

EGFR exon 18 deletion (3)

EGFR exon 2-7 deletion + EGFR amplification (2)

EGFR amplification + ERBB2 amplification (1)

EGFR exon 19 deletion + HER-2 amplification (1)

EGFR exon 21 deletion (1)

EGFR T790M + exon 19 deletion (0)

EGFR amplifcation (0)

›

EGFR mutation + YAP1 overexpression	Lung Adenocarcinoma	EGFR mutation + YAP1 overexpression	Lung Adenocarcinoma	repotrectinib Sensitive: D – Preclinical repotrectinib Sensitive : D	repotrectinib Sensitive: D – Preclinical repotrectinib Sensitive : D
EGFR mutation + YAP1 overexpression	Lung Adenocarcinoma	EGFR mutation + YAP1 overexpression	Lung Adenocarcinoma	dasatinib Sensitive: D – Preclinical dasatinib Sensitive : D	dasatinib Sensitive: D – Preclinical dasatinib Sensitive : D